- PLN69.15m
- PLN64.63m
- PLN0.23m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.21 | ||
| Price to Tang. Book | 7.95 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 312.88 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -15.46% | ||
| Return on Equity | -14.21% | ||
| Operating Margin | -2409.5% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | 0.16 | 0.37 | 0.29 | 0.25 | 0.23 | n/a | n/a | 189.32% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medinice SA is a Poland-based company engaged in medical diagnostic and testing equipment business sector. The Company specializes in creating, developing and commercializing safe and minimally invasive solutions in the field of medicine, in particular cardiology and cardio surgery. Its portfolio comprises of projects, such as CathAIO, Cryoapplicator, Med-IConsole, Minimax, Pacepress and others. All of the Company's projects have a global potential. The Company cooperates with research centers in Poland and Europe. It strives to commercialize inventions brought by both co-founders of the Company and acquired projects through the sale of licenses worldwide in the production of medical devices.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- December 10th, 2012
- Public Since
- September 25th, 2018
- No. of Employees
- 16
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Warsaw Stock Exchange- Shares in Issue
- 6,462,291
- Address
- ul. Hankiewicza 2, WARSZAWA, 02-103
- Web
- https://www.medinice.pl/
- Phone
- Auditors
- KPW Audytor sp. zoo
Upcoming Events for ICE
Similar to ICE
Advanced Medical Equipment SA
Warsaw Stock Exchange
Airway Medix SA
Warsaw Stock Exchange
CM International SA
Warsaw Stock Exchange
Inventionmed SA
Warsaw Stock Exchange
Massmedica SA
Warsaw Stock Exchange
FAQ
As of Today at 21:58 UTC, shares in Medinice SA are trading at PLN10.70. This share price information is delayed by 15 minutes.
Shares in Medinice SA last closed at PLN10.70 and the price had moved by -9.57% over the past 365 days. In terms of relative price strength the Medinice SA share price has underperformed the FTSE Global All Cap Index by -21.98% over the past year.
There is no consensus recommendation for this security.
Find out moreMedinice SA does not currently pay a dividend.
Medinice SA does not currently pay a dividend.
Medinice SA does not currently pay a dividend.
To buy shares in Medinice SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN10.70, shares in Medinice SA had a market capitalisation of PLN69.15m.
Here are the trading details for Medinice SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: ICE
Based on an overall assessment of its quality, value and momentum Medinice SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medinice SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +5.65%.
As of the last closing price of PLN10.70, shares in Medinice SA were trading +11.2% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medinice SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN10.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Medinice SA's directors